GE HealthCare + Hangwei Medical Systems
GE HealthCare
Chicago, Illinois · 2 relationships
Active relationship
Joint Venture · 1991–present
Hangwei Medical Systems
Beijing, Beijing · 1 relationship
Analysis
GE Hangwei is the Beijing-based medical-equipment manufacturing company through which GE HealthCare has maintained a long-running China joint-venture relationship with Sinopharm-linked partners. GE HealthCare's 2023 filing identifies Hangwei as having been formed in 1991 and distinguishes this existing relationship from the separate China National Medical Device Company venture announced in 2023. [1]
The current public footprint is centered on Beijing. GE HealthCare's office directory lists Beijing GE Hangwei Medical Systems Co., Ltd. in the Beijing Economic and Technological Development Area, and its 2025 sustainability report says the Beijing site comprises Hualun and Hang Wei facilities. The report identifies the site as a World Economic Forum Lighthouse Factory and describes Smart Bay heat-exchange and rooftop-photovoltaic initiatives. [2] [3]
Hangwei remains visible in regulatory and product records. The U.S. Food and Drug Administration's current establishment listing names GE Hangwei Medical Systems Co., Ltd. as a trade name under GE Healthcare China, with GE HealthCare Technologies Inc. identified as owner or operator, while a current GE HealthCare CT product page identifies GE Hangwei as the manufacturer of the listed system. [4] [5]
The operating evidence supports describing Hangwei as a continuing manufacturing platform for medical imaging, especially CT, with a modernized Beijing base and export relevance. The public sources used here do not disclose the present equity split, a current Hangwei-only revenue figure or a comprehensive product-volume series, so the original revenue and global-share claims are not repeated. [1] [3]
Participants
Continue through either entity
Chicago, Illinois · 2 records in this database
GE HealthCare Technologies Inc. is a standalone healthcare-technology company that provides medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions. Its investor materials describe a business serving patients and providers for 130 years, with approximately 54,000 colleagues, customers in more than 160 countries, 2025 revenue of $20.6 billion, and an installed base of about five million units. [1] GE HealthCare completed its separation from General Electric effective January 3, 2023 and began trading independently on Nasdaq under the ticker GEHC on January 4. [2]
The company organizes its current offering across Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions. [1] Its imaging activities include molecular imaging, computed tomography, magnetic resonance, women’s health, and X-ray, while its advanced-visualization activities include specialized ultrasound and procedural guidance. [3] Patient Care Solutions includes monitoring and life-support solutions, and Pharmaceutical Diagnostics supplies imaging agents used in diagnostic procedures. [1] [3] GE HealthCare’s precision-care strategy combines imaging, clinical data connectivity, and artificial intelligence to support diagnosis and treatment decisions. [2]
GE HealthCare traces its technical heritage to early medical-imaging work and describes a 125-year innovation legacy that began with some of the earliest X-ray breakthroughs and now extends to AI-enabled devices and connected care. [4] The company’s historical account presents the evolution as a progression from X-ray equipment toward systems that combine images with information about physiology, molecular activity, and treatment response. [4] The 2023 transaction made healthcare a separately governed public company alongside GE’s aviation and energy successors, so GE HealthCare should be treated as its own corporate entity in this database. [2]
Beijing, Beijing · 1 record in this database
GE Hangwei Medical Systems is the Beijing-based medical-device manufacturing entity associated with GE HealthCare China. GE HealthCare’s China profile identifies Hangwei as the first local factory established by GE Medical in China in 1991 through a joint venture with China’s former aerospace and health ministries. [1] The U.S. Food and Drug Administration lists GE HANGWEI MEDICAL SYSTEMS CO., LTD. as a business trade name under GE Healthcare (China) Co., Ltd., at the Beijing Economic-Technological Development Area, with active registration status updated in 2026 and GE HealthCare Technologies Inc. shown as owner/operator. [2]
A GE account of the Beijing medical-systems industrial park records Hangwei’s early progression from trial production of three CT systems in 1991 through technology introduction, technical innovation, subsystem development, participation in global GE product development, and independent development of complete systems in China. [3] The same account describes the Beijing park as a combined engineering, design, production, sales, service, procurement, R&D, training, and product-display site for CT, MR, and X-ray equipment. [3] GE HealthCare’s current China profile says the company now operates six production bases containing seven factories and has a China R&D team of approximately 1,800 people. [1]
Hangwei is also the historical foundation of GE HealthCare’s long-running relationship with Sinopharm. Sinopharm says the two groups had cooperated for more than 30 years since establishing GE Hangwei, which it describes as the result of their first collaboration. [4] In February 2023, Sinopharm’s China National Medical Device Co., Ltd. and GE HealthCare China separately announced a new joint venture for the research, development, and manufacture of high-end medical-imaging equipment, with CMDC holding the majority stake. [4] Hangwei is therefore the earlier manufacturing and localization venture, distinct from that later CMDC transaction. [1] [4]